Mission FD Hosting “Stop the Bleed” Training

Community News
608

Translate to Spanish or other 102 languages!

Program teaches bystanders how to assist in an emergency before help arrives

Mega Doctor News

- Advertisement -

The City of Mission Fire Department is hosting a course called “STOP THE BLEED.” Stop the Bleed is a national awareness campaign and call-to-action. It is intended to cultivate grassroots efforts that encourage everyday citizens to become trained, equipped, and empowered to help in a bleeding emergency before professional help arrives.

When: Saturday, May 18, 2019 8 a.m. – 12 p.m.

Where: Mission Fire Department Central Station – 415 W. Tom Landry Ave. Mission, TX

- Advertisement -

The purpose of the campaign is to better prepare the public to save lives. The program raises awareness of basic actions to stop life-threatening bleeding following everyday emergencies and man-made and natural disasters.

The course is FREE to the public but limited seating is available. If interested, please contact the Mission Fire Department at 956-580-8705

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
IBC Bank Launches Campaign to End Cancer
Next article
Valley Baptist Health System Recognizes May as Mental Health Awareness Month

More Articles

STHS Behavioral Marks Suicide Prevention Month with Community Chalk Event

Every 11 minutes, someone in the United States dies by suicide, according to the Centers for Disease Control and Prevention (CDC), making it one of the nation's leading causes of death.

STHS & Prominence Health Hosting “Senior Living Seminar” on Malnutrition, Sept. 4th

Malnutrition is often an invisible health concern, quietly undermining an older adult's strength, independence and overall quality of life. Yet its warning signs are frequently overlooked or mistaken for a normal part of aging.

STHS Behavioral’s Webinar on Suicide Prevention Awareness, Sept. 3rd

More than 49,000 people died by suicide in the United States in 2023, according to the Centers for Disease Control and Prevention (CDC), making it one of the leading causes of death among adolescents and adults.

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.
- Advertisement -